Cited by 31Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer’s disease

Open access
Brautigam, Hannah, Steele, John W, Westaway, David, Fraser, Paul E, George-Hyslop, Peter H St, Gandy, Sam, Hof, Patrick R, Dickstein, Dara L·2012·Molecular Neurodegeneration

Abstract

Background: The accumulation of amyloid beta (Aβ) oligomers or fibrils is thought to be one of the main causes of synaptic and neuron loss, believed to underlie cognitive dysfunction in Alzheimer’s disease (AD). Neuron loss has rarely been documented in amyloid precursor protein (APP) transgenic mouse models. We investigated whether two APP mouse models characterized by different folding states of amyloid showed different neuronal densities using an accurate method of cell counting. Findings: We examined total cell and neuronal populations in Swedish/Indiana APP mutant mice (TgCRND8) with severe Aβ pathology that includes fibrils, plaques, and oligomers, and Dutch APP mutant mice with only Aβ oligomer pathology. Using the isotropic fractionator, we found no differences from control mice in regional total cell populations in either TgCRND8 or Dutch mice. However, there were 31.8% fewer hippocampal neurons in TgCRND8 compared to controls, while no such changes were observed in Dutch mice. Conclusions: We show that the isotropic fractionator is a convenient method for estimating neuronal content in milligram quantities of brain tissue and represents a useful tool to assess cell loss efficiently in transgenic models with different types of neuropathology. Our data support the hypothesis that TgCRND8 mice with a spectrum of Aβ plaque, fibril, and oligomer pathology exhibit neuronal loss whereas Dutch mice with only oligomers, showed no evidence for neuronal loss. This suggests that the combination of plaques, fibrils, and oligomers causes more damage to mouse hippocampal neurons than Aβ oligomers alone.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1326-7-58

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 13

  1. Selkoe DJ Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein J Alzheimers Dis 2001 3 75 80 12214075
  2. Gandy S Simon AJ Steele JW Lublin AL Lah JJ Walker LC Levey AI Krafft GA Levy E Checler F Glabe C Bilker WB Abel T Schmeidler J Ehrlich ME Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers Ann Neurol 2010 68 220 30 20641005 PMC3094694
  3. Malthankar-Phatak GH Lin YG Giovannone N Siman R Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model Aging Dis 2012 3 141 55 22724075 PMC3377826
  4. Chishti MA Yang DS Janus C Phinney AL Horne P Pearson J Strome R Zuker N Loukides J French J Turner S Lozza G Grilli M Kunicki S Morissette C Paquette J Gervais F Bergeron C Fraser PE Carlson GA George-Hyslop PS Westaway D Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J Biol Chem 2001 276 21562 70 10.1074/jbc.M100710200 11279122 · DOI · Paper page
  5. Herculano-Houzel S Lent R Isotropic fractionator: a simple, rapid method for the quantification of total cell and neuron numbers in the brain J Neurosci 2005 25 2518 21 10.1523/JNEUROSCI.4526-04.2005 15758160 PMC6725175 · DOI · Paper page
  6. Herculano-Houzel S Mota B Lent R Cellular scaling rules for rodent brains Proc Natl Acad Sci U S A 2006 103 12138 43 10.1073/pnas.0604911103 16880386 PMC1567708 · DOI · Paper page
  7. Surchev L Nazwar TA Weisheit G Schilling K Developmental increase of total cell numbers in the murine cerebellum Cerebellum 2007 1 6 17853078
  8. Schmitz C Rutten BP Pielen A Schafer S Wirths O Tremp G Czech C Blanchard V Multhaup G Rezaie P Korr H Steinbusch HW Pradier L Bayer TA Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease Am J Pathol 2004 164 1495 502 10.1016/S0002-9440(10)63235-X 15039236 PMC1615337 · DOI · Paper page
  9. Casas C Sergeant N Itier JM Blanchard V Wirths O van der Kolk N Vingtdeux V van de Steeg E Ret G Canton T Drobecq H Clark A Bonici B Delacourte A Benavides J Schmitz C Tremp G Bayer TA Benoit P Pradier L Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model Am J Pathol 2004 165 1289 300 10.1016/S0002-9440(10)63388-3 15466394 PMC1618627 · DOI · Paper page
  10. Breyhan H Wirths O Duan K Marcello A Rettig J Bayer TA APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy Acta Neuropathol 2009 117 677 85 10.1007/s00401-009-0539-7 19387667 · DOI · Paper page
  11. Lublin AL Gandy S Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's Disease Mt Sinai J Med 2010 77 43 9 10.1002/msj.20160 20101723 PMC3306842 · DOI
  12. Lefterov I Fitz NF Cronican A Lefterov P Staufenbiel M Koldamova R Memory deficits in APP23/Abca1+/− mice correlate with the level of Abeta oligomers ASN Neuro 2009 1 PMC2695585 19570031
  13. Dickstein DL Brautigam H Stockton SD Jr Schmeidler J Hof PR Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau Brain Struct Funct 2010 214 161 79 10.1007/s00429-010-0245-1 20213269 PMC3032082 · DOI

Cited by

Sorted by citations

Authors
Brautigam, H., Steele, J. W., Westaway, D., Fraser, P. E., George-Hyslop, P. H. S., Gandy, S., Hof, P. R., & Dickstein, D. L.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • James J. Peters VA Medical Center (US)
  • University of Alberta (CA)
  • University of Toronto (CA)
Corresponding author
Dickstein, Dara L
Venue
Molecular Neurodegeneration
Published
2012-11-22
Volume
7
Issue
1
Pages
58-58
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2146150930
Cited by
31
References
4
Citations by year
2025: 1 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 1 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3
FWCI
1.50
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Howard Hughes Medical Institute
  • Wellcome Trust (081864)
  • Alzheimer Society
  • Fondation pour la Recherche Médicale
  • Universidade Federal do Rio de Janeiro
  • National Institutes of Health (AG05138, AG10491)
  • Canadian Institutes of Health Research (MOP115056)
  • Medical Research Council
  • National Institute on Aging (P01AG010491, P50 AG 05138, P50AG005138, P01 AG10491, F31AG039890, AG039890, P30AG066514)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, hippocampal neuronal loss, amyloid-beta oligomers, amyloid fibrils, amyloid plaques, TgCRND8 mice, amyloid precursor protein
MeSH terms
Alzheimer Disease, Animals, Cell Count, Cell Fractionation, Disease Models, Animal, Hippocampus, Mice, Transgenic, Neurons, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review